These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11084685)

  • 21. Epidermal stem cells as targets for gene transfer.
    Watt FM
    Hum Gene Ther; 2000 Nov; 11(16):2261-6. PubMed ID: 11084684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy approaches for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Mavilio F; De Luca M
    Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Durable and stratum-specific gene expression in epidermis.
    Ghazizadeh S; Doumeng C; Taichman LB
    Gene Ther; 2002 Oct; 9(19):1278-85. PubMed ID: 12224010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First symposium on natural gene therapy of the skin.
    Pasmooij AM; Jonkman MF
    Exp Dermatol; 2012 Mar; 21(3):236-9. PubMed ID: 22379975
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.
    Uitto J
    Acta Derm Venereol; 2009; 89(3):228-35. PubMed ID: 19479117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in epidermolysis bullosa: genetic classification and clinical implications.
    Uitto J; Richard G
    Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):61-74. PubMed ID: 15468152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy.
    Pasmooij AM; Jonkman MF; Uitto J
    Discov Med; 2012 Sep; 14(76):167-79. PubMed ID: 23021371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
    Peking P; Koller U; Murauer EM
    Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
    Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
    Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-based prenatal diagnosis of heritable skin diseases.
    Christiano AM; Uitto J
    Arch Dermatol; 1993 Nov; 129(11):1455-9. PubMed ID: 7902070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inherited skin diseases - a review of selected genodermatoses].
    Wertheim-Tysarowska K; Gos M; Niepokój K; Kowalewski C
    Med Wieku Rozwoj; 2012; 16(3):183-95. PubMed ID: 23378396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratinocyte gene therapy.
    Vogel JC
    Arch Dermatol; 1993 Nov; 129(11):1478-83. PubMed ID: 8239704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics of heritable blistering disorders.
    Uitto J; Pulkkinen L
    Arch Dermatol; 2001 Nov; 137(11):1458-61. PubMed ID: 11708948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in skin gene therapy.
    Pfützner W; Vogel JC
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2069-83. PubMed ID: 11060793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revertant mosaicism in genodermatoses.
    Lim YH; Fisher JM; Choate KA
    Cell Mol Life Sci; 2017 Jun; 74(12):2229-2238. PubMed ID: 28168442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
    Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
    Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preclinical model for the analysis of genetically modified human skin in vivo.
    Del Rio M; Larcher F; Serrano F; Meana A; Muñoz M; Garcia M; Muñoz E; Martin C; Bernad A; Jorcano JL
    Hum Gene Ther; 2002 May; 13(8):959-68. PubMed ID: 12031128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited epidermolysis bullosa. Clinical features, molecular genetics, and pathoetiologic mechanisms.
    Uitto J; Christiano AM
    Dermatol Clin; 1993 Jul; 11(3):549-63. PubMed ID: 8365039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.